Rules in work, health, and finance

Workplace AI can assist with sourcing, résumé analysis, interview scheduling, assessment, performance management, productivity monitoring, promotion, discipline, and termination. Risk rises when a system moves from administration toward evaluation or adverse action.

Important questions include:

• Does the tool directly or indirectly rank people?
• Were training and validation data representative of the relevant jobs and applicants?
• Could names, addresses, schools, gaps, disability-related behavior, accents, or proxies produce unequal effects?
• Are candidates or workers told about the system where appropriate?
• Can they request an accommodation, correct data, or obtain human review?
• Are managers trained not to treat a score as objective fact?

Validation should match the claimed use. A personality inference from facial movement or voice deserves skepticism: polished charts do not establish that a measurement is job-relevant or scientifically sound. A vendor’s overall accuracy is not enough if outcomes differ by role, language, disability, or demographic group.

Human review must occur before consequential action and have substance. A recruiter who sees only a model’s score cannot identify a résumé parsing error. Provide source evidence and prohibit unsupported use. Keep records that can reconstruct what influenced the decision while respecting applicant privacy and retention limits.

Health-related AI ranges from appointment reminders and billing support to image analysis, triage, treatment recommendations, and patient-facing advice. Do not classify all “health AI” together. Administrative uses can still expose sensitive data, while diagnostic or treatment functions can directly affect safety and may enter medical-device or professional-practice frameworks.

Ask:

• Is the output informational, administrative, clinical support, or a diagnosis or treatment direction?
• Which patient population and care setting were used for evaluation?
• Does performance hold across age, sex, skin tone, language, equipment, and disease prevalence where relevant?
• What happens when data is missing, low quality, or outside the validated population?
• Can a qualified professional inspect evidence and override the output?
• How quickly can the organization detect and respond to harm?

Clinical performance depends on context. A model tested in one hospital may behave differently with another hospital’s workflows or patient mix. A statistically strong average can hide poor sensitivity for a rare but dangerous condition.

Patient-facing language should not overstate certainty. The interface should route urgent or ambiguous cases safely rather than offering a confident guess. Privacy protections must cover notes, images, audio, identifiers, derived predictions, and vendor access.

Financial AI may support credit, insurance, payments, fraud detection, collections, investment services, and customer support. These uses can affect access to essential resources and may be governed by detailed sector rules in addition to privacy and anti-discrimination law.

Key questions include:

• Does the model influence approval, price, limit, investigation, or account restriction?
• Are input data accurate, relevant, permitted, and correctable?
• Could location, device, shopping behavior, or other proxies create unfair outcomes?
• Can the organization provide accurate reason codes for an adverse outcome?
• How are false positives handled, especially when accounts or payments are frozen?
• Is the system robust against manipulation without treating unusual behavior as wrongdoing?

Fraud systems illustrate the tradeoff between missed fraud and false accusation. Raising a threshold may reduce fraud losses while blocking legitimate customers. Monitor both outcomes and examine who bears the burden. An appeal that takes two weeks is not meaningful when someone needs access to wages today.

Do not generate explanations by asking a model to invent a reason. Preserve the actual policy factors and verified data that drove the action.

Work, health, and finance share a control pattern:

1. Define the exact use and professional context.
2. Involve domain experts, not only model specialists.
3. Test on representative conditions and important subgroups.
4. Limit automation according to consequence and evidence.
5. Give reviewers source information, authority, and time.
6. Inform affected people and provide correction or challenge routes.
7. Monitor real outcomes, incidents, and unequal impacts.
8. Reassess after changes in model, data, workflow, population, or law.

Procurement does not remove these duties. A vendor may provide model evidence, but the deploying organization understands local workflow, users, and affected populations. Contracts should support access to necessary documentation, change notices, incident cooperation, and exit plans.